Immune T cell defence is coping with COVID-19 variants of concern – for now


Join us in The Bullpen, where the members of the Scientific Inquirer community get to shape the site’s editorial decision making. We’ll be discussing people and companies to profile on the site. On Wednesday, December 14 at 5:30pm EST, join us on Discord and let’s build the best Scientific Inquirer possible.

Immune T cells are continuing to target the spike protein of SARS-CoV-2 variants of concern, although mutations are making some T cells less effective, according to new research.

Published in Nature Immunology, researchers from the University of Birmingham have shown that human T cell immunity is currently coping with mutations that have accumulated over time in COVID-19 variants.

In the study, funded by the National Institute for Health and Care Research, the research partner of the NHS, the researchers tested CD4+ T cells collected at the start of the pandemic from healthcare workers infected with COVID-19.

ON SALE! Charles Darwin Signature T-shirt – “I think.” Two words that changed science and the world, scribbled tantalizingly in Darwin’s Transmutation Notebooks.

Some of the T-cells were still able to recognise parts of the spike protein, called epitopes, unaltered in later virus strains including the current Omicron variant. However, T cell recognition was worse against seven out of ten epitopes mutated in different variants of concern.

The researchers caution that as SARS-CoV-2 continues to mutate, T-cell recognition of additional epitopes could be lost decreasing overall protection by the immune system.

Dr Heather Long, Associate Professor in the Institute of Immunology and Immunotherapy at the University of Birmingham and lead author of the research said:

“Our paper shows that although most people have a diverse T cell response against the virus, some responses are less effective against Omicron. As further variants of concern are identified we will need to consider carefully how new viral mutations affect T-cell recognition.”

Dr Graham Taylor, Associate Professor in the Institute of Immunology and Immunotherapy at the University of Birmingham said:

“The vaccines currently in use are still vital to protect us from COVID-19. Should SARS-CoV-2 continue to mutate to evade the immune system, our findings will help researchers to develop new vaccines better suited to those variants.”


Success! You're on the list.

Human hippocampus theta oscillations code goal distance during spatial navigation
A research team led by Dr. WANG Liang from the Institute of …
The Big Picture: The roadrunner running things.
Roadrunners, native to the southwestern U.S. and Mexico, are an iconic symbol …

Leave a Reply

%d bloggers like this: